We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmaceutical firm Elan announced Tuesday it has dropped doses in a clinical trial of a new drug
it has been testing for Alzheimer’s
disease. The Irish Times
